← Leaderboards
Isaac Jonathan Krauss
Brandeis University
$9,350,910
Attributed
$9,350,910
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,350,910 · 8
By mechanism
R01$7,283,043 · 3
R21$899,849 · 2
R56$523,424 · 1
S10$482,094 · 1
R03$162,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Affinity”
- Dennis R. Burton · Scripps Research Institute$64,397,776
- James E Crowe · Vanderbilt University Medical Center$53,471,415
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$45,445,140
- Timothy A Springer · Boston Children'S Hospital$41,593,445
- Misty Ward Stevens · Intervexion Therapeutics, Llc$38,187,594
- Rafi Ahmed · Emory University$36,776,987
Research focus
AffinityPolysaccharidesViralAntibodiesLibrariesAntigensPeptidesStructureResponseDesignGlycopeptidesNeutralizing AntibodyEpitopesVaccinesBindingInfectionImmunogenicityElementsMannoseComplexHiv Envelope Protein Gp120EvolutionOryctolagus CuniculusCarbohydrates
Grant awards (25)
Technologies for Directed Evolution of Glycoaptamers$317,507
R01 · FY2025 · GM · contact PI
Technologies for Directed Evolution of Glycoaptamers$317,178
R01 · FY2024 · GM · contact PI
Mannosidase-stabilized glycan immunogens for elicitation of high mannose patch antibodies$203,125
R21 · FY2024 · AI · contact PI
Technology for Directed Evolution of Glycoaptamers$160,926
R01 · FY2024 · GM · contact PI
A 400 MHz NMR Spectrometer$482,094
S10 · FY2023 · OD · contact PI
Technologies for Directed Evolution of Glycoaptamers$421,249
R01 · FY2023 · GM · contact PI
Mannosidase-stabilized glycan immunogens for elicitation of high mannose patch antibodies$243,750
R21 · FY2023 · AI · contact PI
Glycoantigen evolution targeting antibodies of the PGT 128 lineage$525,019
R01 · FY2022 · AI · contact PI
Glycoantigen evolution targeting antibodies of the PGT 128 lineage$560,769
R01 · FY2021 · AI · contact PI
Glycoantigen evolution targeting antibodies of the PGT 128 lineage$587,087
R01 · FY2020 · AI · contact PI
Glycoantigen evolution targeting antibodies of the PGT 128 lineage$563,012
R01 · FY2019 · AI · contact PI
Directed Evolution of Zika EDE Glycoantigens$124,644
R21 · FY2019 · AI · contact PI
The Effect of Extended Antigen Release on Carbohydrate Specificity of the Antibody Response$81,250
R03 · FY2019 · AI · contact PI
Design of Immunogens to Elicit PGT122 like Antibodies$423,961
R01 · FY2018 · AI · contact PI
Directed Evolution of Zika EDE Glycoantigens$328,330
R21 · FY2018 · AI · contact PI
The Effect of Extended Antigen Release on Carbohydrate Specificity of the Antibody Response$81,250
R03 · FY2018 · AI · contact PI
Glycopeptide evolution targeting antibodies of the PGT128 lineage.$523,424
R56 · FY2017 · AI · contact PI
Design of Immunogens to Elicit PGT122 like Antibodies$423,961
R01 · FY2017 · AI · contact PI
Design of Immunogens to Elicit PGT122 like Antibodies$475,149
R01 · FY2016 · AI · contact PI
Design of Immunogens to Elicit PGT122 like Antibodies$489,149
R01 · FY2015 · AI · contact PI
Design of Immunogens to Elicit PGT122 like Antibodies$362,154
R01 · FY2014 · AI · contact PI
Rational and Combinatorial Design of Immunogens to Elicit 2G12-like Antibodies$397,874
R01 · FY2013 · AI · contact PI
Rational and Combinatorial Design of Immunogens to Elicit 2G12-like Antibodies$540,103
R01 · FY2012 · AI · contact PI
Rational and Combinatorial Design of Immunogens to Elicit 2G12-like Antibodies$351,945
R01 · FY2011 · AI · contact PI
Rational and Combinatorial Design of Immunogens to Elicit 2G12-like Antibodies$366,000
R01 · FY2010 · AI · contact PI